Success Metrics

Clinical Success Rate
100.0%

Based on 18 completed trials

Completion Rate
100%(18/18)
Active Trials
4(15%)
Results Posted
56%(10 trials)

Phase Distribution

Ph phase_1
3
12%
Ph phase_2
16
62%
Ph not_applicable
3
12%
Ph phase_4
4
15%

Phase Distribution

3

Early Stage

16

Mid Stage

4

Late Stage

Phase Distribution26 total trials
Phase 1Safety & dosage
3(11.5%)
Phase 2Efficacy & side effects
16(61.5%)
Phase 4Post-market surveillance
4(15.4%)
N/ANon-phased studies
3(11.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.7%

18 of 19 finished

Non-Completion Rate

5.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

26

all time

Status Distribution
Active(5)
Completed(18)
Terminated(1)
Other(2)

Detailed Status

Completed18
Recruiting4
Withdrawn1
Not yet recruiting1
unknown1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (11.5%)
Phase 216 (61.5%)
Phase 44 (15.4%)
N/A3 (11.5%)

Trials by Status

withdrawn14%
not_yet_recruiting14%
recruiting415%
unknown14%
completed1869%
suspended14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT06188923Phase 2

A New Intervention to Improve Function in Veterans With Anxiety and Depression

Recruiting
NCT05935761Phase 2

Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

Not Yet Recruiting
NCT02627508Phase 2

Pilot Trial of Pregnenolone in Autism

Completed
NCT05781009Phase 2

Pregnenolone for the Treatment of Alcohol Use Disorder

Recruiting
NCT05671692Phase 2

Novel Intervention for Chronic Complex TBI in OEF/OIF/OND Veterans

Suspended
NCT03505905Phase 1

A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

Completed
NCT03799562Phase 2

Neurosteroids for PTSD in Veterans

Completed
NCT06238700Not Applicable

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

Recruiting
NCT05570812Phase 2

Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Recruiting
NCT02582905Phase 4

Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

Completed
NCT01956279Phase 2

Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)

Completed
NCT01336413Phase 2

Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans

Completed
NCT01898013Phase 2

Neurosteroids as Novel Therapeutic Agents for Chronic Pain in OEF/OIF Veterans

Completed
NCT02439814Phase 2

Pregnenolone and Marijuana Dependence

Completed
NCT01881737Phase 2

A Study of Pregnenolone in the Treatment of Individuals With Autism

Completed
NCT01409096Phase 4

Study Using Pregnenolone to Treat Bipolar Depression

Completed
NCT00615511Phase 2

Efficacy of Pregnenolone in Patients With Schizophrenia

Completed
NCT00560937Not Applicable

Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia

Completed
NCT00993629Phase 2

Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans

Withdrawn
NCT00623506Not Applicable

Adjunctive Pregnenolone in Veterans With Mild TBI

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26